Validation of color doppler eus for azygos blood flow measurement in patients with cirrhosis: Application to the acute hemodynamic effects of somatostatin, octreotide, or placebo

Gastrointestinal Endoscopy

Volumn 54, Issue 1, 2001, Pages 24-30

  Nishida, Hitoshi ^a,b   Giostra, Emile ^a,b   Spahr, Laurent ^a,b   Mentha, Gilles ^a,b   Mitamura, Keiji ^a,b   Hadengue, Antoine ^a,b  

^a Department of Gastroenterology and Hepatology ^*  (Switzerland)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN;

AGED; ARTICLE; AZYGOS VEIN; BLOOD FLOW VELOCITY; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; EVALUATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; THERMODILUTION; TREATMENT OUTCOME;

AGED; AZYGOS VEIN; BLOOD FLOW VELOCITY; DOUBLE-BLIND METHOD; ENDOSONOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PORTAL; INJECTIONS, INTRAVENOUS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OCTREOTIDE; REPRODUCIBILITY OF RESULTS; SOMATOSTATIN; THERMODILUTION; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0035406939     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2001.115336     Document Type: Article

References (33)

1. Hadengue A. Somatostatin Or octreotide in acute variceal bleeding. Digestion 1999;60(Suppl 2):31-41.
2. Sung JJ, Chung SC, Yung MY, Lai CW, Lau JY, Lee YT, et al. Prospective randomized study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995;346:1666-9.
3. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-60.
4. Avgerinos A, Nevens F, Raptis S, Fevery J, ABOVE Study Group. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial. Lancet 1997;350:1495-9.
5. Burroughs AK, the International Octreotide Varices Study Group. Double-blind RCT of 5 days octreotide versus placebo, associated with sclerotherapy for trial failures [abstract]. Hepatology 1996;24(Suppl 4):352A.
6. Panes J, Pique JM, Bordas JM, Casadevall M, Teres J, Bosch J, et al. Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994;20:336-41.
7. McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, Mcintyre N, et al. Cardiovascular effects of octreotide in patients with cirrhosis, Hepatology 1995;21:1255-60.
8. Cirera I, Feu F, Luca A, Garcia-Pagan JC, Fernandez M, Escorsell A, et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology 1995;22:106-11.
9. Escorsell A, Bandi JC, François E, Moitinho E, Andreu V, Palacios A, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension [abstract]. Hepatology 1996;24(Suppl 4):207A.
10. Moller S, Brinch K, Henriksen JH, Becker U. Effect of octreotide On systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 1997;26:1026-33.
11. Variceal Bleeding Study Group. A multicenter randomized controlled trial comparing different schedules of somatostatin administration in the treatment of acute variceal bleeding [abstract]. Hepatology 1998;28:A770.
12. Lee SY, Sung JJ, Yung MY, Yu AL, Chung SC. Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertension. Gastrointest Endosc 1999;50:47-52.
13. Bosch J, Groszmann RI. Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 1984;4:424-9.
14. D'Amico G, Montalbano L, Traina M, Pisa R, Menozzi M, Spano C, et al. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990;99:1558-64.
15. Gostout CJ, Viggiano TR, Balm RK. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol 1993;88:2030-3.
16. Kiel JW, Riedel GL, DiResta GR, Shepherd AP. Gastric mucosal blood flow measured by laser-Doppler flowmetry. Am J Physiol 1985;249:G539-45.
17. Ahn H, Ivarsson LE, Johansson K, Lindhagen J, Lundgren O, Assessment of gastric blood flow with laser Doppler flowmetry. Scand J Gastroenterol 1988;23:1203-10.
18. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988;319:983-9.
19. Salama ZA, Kassem AM, Giovannini M, Hunter MS. Endoscopic ultrasonographic study of the azygos vein in patients with varices. Endoscopy 1997;27:748-50.
20. Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Sakaki M, et al. Observer agreement and variability in measuring gastric mucosal blood flow by laser Doppler flowmetry in humans. Endoscopy 1997;25:274-7.
21. Casadevall M, Panes J, Pique JM, Bosch J, Teres J, Rodes J. Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. Am J Physiol 1992;263:G810-5.
22. Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodes J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. J Hepatol 1985;1:125-39.
23. Cales P, Braillon A, Jirin I, Lebrec D. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. J Hepatol 1984;1:37-46.
24. Sugihara H, Minami S, Wakabayashi I. Post-somatostatin rebound secretion of growth hormone is dependent on growth hormone-releasing factor in unrestrained female rats. J Endocrinol 1989;122:583-91.
25. Lamberts SWJ, Oosterom R, Neufeld M, del Pozo E. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients. J Clin Endocrinol Metab 1985;60:1161-5.
26. Bauer W, Briner U, Doepfner W. SMS 201-95: a very potent and selective octapeptide analogue of somatostatin with pro-longed action. Life Sci 1982;31:1133-40.
27. Ottesen L, Flyvbjerg A, Jakobsen P, Bendtsen F. The pharmacokinetics of octreotide in cirrhosis and in healthy men. J Hepatol 1997;26:1018-25.
28. Jenkins SA, Nott DM, Baxter JN. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure. HBP Surg 1998;11:13-21.
29. Panes J, Bordas JM, Pique JM, Bosch J, Garcia-Pagan JC, Feu F, et al. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 1992;103:1876-82.
30. Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Harada H, et al. Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy. Hepatology 1993;18:36-40.
31. Panes J, Pique JM, Bordas JM, Llach J, Bosch J, Teres J, et al. Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy. Hepatology 1994;19:55-60.
32. Li MKK, Sung JJY, Woo KS, Sanderson J, Leung NWY, Yu LM, et al. Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy, A randomized, double-blind crossover study. Dig Dis Sci 1996;41:2440-6.
33. Yamamoto Y, Sezai S, Sakurabayashi S, Hirano M, Oka H. Effect of hepatic collateral hemodynamics on gastric mucosal blood flow in patients with liver cirrhosis. Dig Dis Sci 1992;37:1319-23.